Harbin Songhe Pharmaceutical

Harbin Songhe Pharmaceutical is a comprehensive pharmaceutical enterprise based in Harbin, China, specializing in the research, development, and manufacturing of Traditional Chinese Medicines (TCM) and chemical pharmaceuticals. The company operates large-scale, GMP-certified production facilities capable of producing various dosage forms, including tablets, capsules, and injections. Its therapeutic focus primarily encompasses cardiovascular health, cerebrovascular disorders, and anti-inflammatory treatments. Harbin Songhe is recognized as a significant player in the regional Heilongjiang pharmaceutical sector, leveraging its Songhe brand to distribute products across the Chinese domestic market. The company's portfolio includes well-known formulations such as Compound Salvia Miltiorrhiza and Pudilan Xiaoyan.